Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1273 clinical trials
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

Cellular and humoral immune responses before and after seasonal influenza vaccination will be assessed. Each year, up to 100 participants will be enrolled. To study age-specific differences in

influenza vaccination
trivalent influenza vaccine
Accepts healthy volunteers
vaccination
  • 4 views
  • 14 Nov, 2021
  • 1 location
SCALE-UP Utah: Community-Academic Partnership to Address COVID-19 Vaccination Rates Among Utah Community Health Centers

Community Health Centers: Text Messaging (TM): population health management (PHM) intervention that analyzes EHR data to automatically identify patients eligible for COVID-19 vaccination and

Accepts healthy volunteers
  • 0 views
  • 25 Apr, 2022
  • 1 location
Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study

Indian communities. The goal of this study is to 1) understand the barriers and social implications of COVID19 testing and vaccination among American Indians by designing and implementing culturally

  • 0 views
  • 26 Jul, 2021
  • 1 location
A Study of S-268019 for the Prevention of COVID-19

The main purpose of this study is to assess the efficacy of S-268019-b for the prevention of COVID-19 in the initial vaccination period prior to crossover in participants without evidence of

Accepts healthy volunteers
  • 0 views
  • 26 Mar, 2022
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza

. Participants will receive at Vaccination 1 either: 1 of 4 dose levels of mIRV (either A or B Strain), 1 of 4 dose levels of bIRV (containing both A and B strains), qIRV (at 1

quadrivalent inactivated influenza vaccine
trivalent influenza vaccine
influenza vaccination
strain
vaccination
  • 0 views
  • 09 Jun, 2022
  • 78 locations
COVID-19 VACCINE SAFETY AND EFFECTIVENESS

standard 3-dose schedule with an interval of 12 weeks (first-second dose) and 24 weeks (second-thrid dose), in the vaccination campaign against SARS-CoV-2 to assess the safety, efficacy and duration of the

Accepts healthy volunteers
  • 0 views
  • 02 Dec, 2021
  • 1 location
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness (Text&Talk)

This study will test the effectiveness of two interventions (parent-targeted text messages and a brief clinician-targeted training) at increasing HPV vaccination among 11- to 12-year-olds living

Accepts healthy volunteers
  • 0 views
  • 17 Mar, 2022
  • 1 location
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

age. To describe the antibody response against meningococcal serogroups A, C, Y, and W 30 days after the second vaccination at 12 to 13 months of age with MenACYW conjugate vaccine or MENVEO

Accepts healthy volunteers
  • 0 views
  • 13 May, 2022
  • 51 locations
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, and Children in India and Healthy Adolescents and Children in the Republic of South Africa (MET55)

meningococcal serogroups A, C, Y, and W before and at Day 30 after vaccination with MenACYW conjugate vaccine or a licensed meningococcal vaccine in adults in India aged 18 to 55 years (Menactra®) or ≥ 56 years

Accepts healthy volunteers
  • 0 views
  • 13 May, 2022
  • 12 locations
Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children

follow-up after the first vaccination.

tetanus
boostrix
diphtheria
Accepts healthy volunteers
vaccination
  • 0 views
  • 25 Mar, 2022
  • 3 locations